ANTI-MYELIN ASSOCIATED GLYCOPROTEIN (MAG) ANTIBODY - ANVISA Registration 10338930216
Access comprehensive regulatory information for ANTI-MYELIN ASSOCIATED GLYCOPROTEIN (MAG) ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930216 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including EUROIMMUN AG, EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10338930216
25351691579201894
93741726000166
Company Information
Dates and Status
Mar 18, 2019
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTI-GLICOPROTEÍNA ASSOCIADA À MIELINA (MAG)
Anti-MAG Antibodies (ELISA)
BUHLMANN LABORATORIES AG
80102513168
Jan 02, 2024
ANTICORPO ANTI-GLICOPROTEÍNA ASSOCIADA À MIELINA (MAG)
Anti-Myelin-Oligodendrocyte Glycoprotein (MOG) IIFT
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
10338930300
Nov 20, 2023
ANTICORPO ANTI-GLICOPROTEÍNA ASSOCIADA À MIELINA (MAG)
IF: Anti-nervos medulares
EUROIMMUN AG
81148560055
Jun 12, 2017

